Opioid Neuronal Denervation in Gilles de la Tourette Syndrome

References

• Bleeker H. E. Gilles de la Tourettes' syndrome with direct evidence of organicity. Psychiatric Clinic 1978; 11: 147–154
   PubMedGoogle Scholar
• Butler I. J., Koslow S. H., Seifert W. C. Biogenic amine metabolism in Tourette syndrome. Annals of Neurology 1979; 3: 224–230
   Google Scholar
• Casas-Bruge M., Almenar C., Grau I. M., Jane J., Herrera-Marschitz M., Ungerstedt U. Dopaminergic receptor supersensitivity in self-mutilation behavior of Lesch-Nyhan disease. Lancet 1985; 1: 991
   PubMed Web of Science ®Google Scholar
• Coid J., Allolio B., Rees L. H. Raised plasma metenkephalin in patients who habitually mutilate themselves. Lancet 1983; 1: 545–546
   PubMed Web of Science ®Google Scholar
• Dahlin P. A., VanBuskirk N. E., Novotny R. W., Hollis I. R., George J. Self-biting with multiple finger amputation following spinal cord injury. Paraplegia 1985; 23: 306–318
   PubMedGoogle Scholar
• Erenberg G., Crase R. P., Rothner A. D. Gilles de la Tourette's syndrome: effects of stimulant drugs. Neurology 1985; 35: 1346–1348
   PubMed Web of Science ®Google Scholar
• Eriksson B., Persson T. Gilles de la Tourette's syndrome. Two cases with an organic brain injury. British Journal of Psychiatry 1969; 115: 351–353
   PubMed Web of Science ®Google Scholar
• Fisarova M., Kule J. Syndrom Gilles de la Tourette. Czechoslovakia Psychiatria 1967; 63: 231–235
   Google Scholar
• Gillberg C., Terenius L., Lonnerholm G. Childhood psychosis:spinal fluid levels in 24 cases. Archives of General Psychiatry 1985; 42: 780–783
   PubMed Web of Science ®Google Scholar
• Glick S. D. Changes in drug sensitivity and mechanisms of functional recovery following brain damage in Plasticity and recovery of function in the central nervous system. Academic Press, New York 1974
   Google Scholar
• Goldstein M., Kuga S., Kusano N., Meller E., Dancis J., Schwarcz R. Dopamine agonist induced self-mutilitative biting behavior in monkeys with unilateral ventromedial lesions of the brainstem: possible pharmacological model for Lesch-Nyhan syndrome. Brain Research 1986; 367: 114–120
   PubMed Web of Science ®Google Scholar
• Herman B. H., Panksepp J. Ascending endorphin inhibition of distress vocalization. Science 1981; 211: 1060–1062
   PubMed Web of Science ®Google Scholar
• Klempel K. Gilles de la Tourette's symptoms induced by L-dopa. South African Medical Journal 1974; 48: 1379–1380
   PubMed Web of Science ®Google Scholar
• Lakke J., Wilmink J. T. A case of Gilles de la Tourette's syndrome with midbrain involvement. Journal of Neurology, Neurosurgery and Psychiatry 1985; 48: 1293–1296
   PubMed Web of Science ®Google Scholar
• Lesch M., Nyhan W. L. A familial disorder of uric acid metabolism and central nervous system function. American Journal of Medicine 1964; 36: 561–570
   PubMed Web of Science ®Google Scholar
• Murray T. J. Tourette's syndrome: A treatable tic. Canadian Medical Association Journal 1978; 118: 1407–1410
   PubMed Web of Science ®Google Scholar
• Nyback H., Sedvall G. Effect of nigral lesion on chlropromazine-induced acceleration of dopamine synthesis from (14C) tyrosine. Journal of Pharmacy and Pharmacology 1970; 23: 322–326
   Web of Science ®Google Scholar
• Paine R. S. Minimal chronic brain syndromes in children. Developmental Medicine and Child Neurology 1962; 4: 21–27
   PubMedGoogle Scholar
• Pulst S. M., Walsh T. M., Romero J. A. Carbon monoxide poisoning with features of Gilles de la Tourettes' syndrome. Archives of Neurology 1983; 40: 443–444
   PubMedGoogle Scholar
• Richardson J. S., Zaleski W. A. Naloxone and self-mutilation. Biological Psychiatry 1983; 18: 99–101
   PubMed Web of Science ®Google Scholar
• Sandyk R. Naloxone abolishes self-injuring in a mentally retarded child. Annals of Neurology 1985a; 17: 520
   PubMed Web of Science ®Google Scholar
• Sandyk R., Gillman M. A. Transient Gilles de la Tourette syndrome following alcohol withdrawal. British Journal of Addiction 1985; 80: 213–214
   PubMedGoogle Scholar
• Sandyk R. Phenobarbital-induced Tourette's-like symptoms. Pediatric Neurology 1986a; 2: 54–55
   PubMedGoogle Scholar
• Sandyk R. Naloxone ameliorates autoaggressive behavior in Tourette's syndrome. Neurology 1986b; 36((suppl. 1))275
   Google Scholar
• Sandyk R. Naloxone withdrawal exacerbates Tourette syndrome. Journal of Clinical Psychopharmacology 1986c; 6: 58–59
   PubMed Web of Science ®Google Scholar
• Sandyk R., Iacono R. P., Bamford C. R. The hypothalamus in Tourette's syndrome. International Journal of Neuroscience, (in press)
   Google Scholar
• Sandyk R., Iacono R. P. (1986) The hypothalamus in Gilles de la Tourette syndrome. Presented at the Child Neurology Society Meeting, Boston, Massachusetts, October, 1986, (abstract)
   Google Scholar
• Shapiro A. K., Shapiro E., Bruun R. D. Gilles de la Tourette Syndrome. Raven Press, New York 1978
   Google Scholar
• Silverstein F. S., Johnson M. V., Hutchinson R. J., Edwards N. L. Lesch-Nyhan syndrome: CSF neurotransmitter abnormalities. Neurology 1985; 35: 907–911
   PubMed Web of Science ®Google Scholar
• Singer H. S., Butler I. J., Tune L. E., Seifert W. E., Coyle J. T. Dopaminergic dysfunction in Tourette syndrome. Annals of Neurology 1982; 13: 361–366
   Google Scholar
• Sweet R. D., Solomon G. E., Wayne H., Shapiro E., Shapiro A. K. Neurological features of Gilles de la Tourette syndrome. Journal of Neurology, Neurosurgery and Psychiatry 1973; 36: 1–9
   PubMed Web of Science ®Google Scholar
• Ungerstedt U. Post-synaptic supersensitivity after 6-hydroxydopamine-induced degeneration of the nigro-striatal dopamine system. Acta Physiologica Scandinavica 1971; 361((suppl.))69–93
   Google Scholar
• VanWoert M. H., Jutkowitz R., Rosenbaum D. Gilles de la Tourette's syndrome: Biochemical approaches in M. D. Yahr. The basal ganglia(Ed.). Raven Press, New York 1979; 459–465
   Google Scholar